An interview discussing his break-throughs in molecular biology, thrombotic hazards of Cox II inhibitors and the relationships between molecular clocks and aging.
The overarching goal of Dr. Spann’s research is to identify early immune, brain, and neuropsychological antecedents of childhood psychiatric risk to reduce the time to intervention for young children